Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan;45(1):20-24.
doi: 10.1111/ced.14064. Epub 2019 Aug 29.

Functional symptoms in dermatology: Part 2

Affiliations
Review

Functional symptoms in dermatology: Part 2

S L Ball et al. Clin Exp Dermatol. 2020 Jan.

Abstract

Functional disorders within dermatology present as various constellations of skin symptoms, but without evidence of organic pathology. Examples can include mucocutaneous pain syndromes, functional pruritus, somatoform pain disorder and rarer entities, such as undifferentiated somatoform idiopathic anaphylaxis and multiple chemical sensitivity syndrome. These conditions can have a significant impact on a patient's quality of life, and can present challenges in communication, investigation and management. The aetiology of functional disorders is not fully understood, but with an effective collaborative approach, a psychological explanation for these symptoms is often found. A structured approach to assessment can lead to a confident diagnosis, and understanding a patient's belief system and the impact of symptoms on their functioning can give better grounding for successful management. Treatment is dependent on the level of the patient's engagement with healthcare professionals, and often takes a measured and rehabilitative approach. Psychological therapies have been shown to be effective, often alongside both psychopharmacological and topical medications.

PubMed Disclaimer

References

    1. Carson A, Ringbauer B, Stone J. Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinics. J Neurol Neurosurg Psychiatry 2000; 68: 207-10.
    1. Howard LM, Wessely SJ. Reappraising reassurance - the role of investigations. Psychosom Res 1996; 41: 307-11.
    1. Kirmayer LJ, Groleau D, Looper KJ, Dao MD. Explaining medically unexplained symptoms. Can J Psychiatry 2004; 49: 663-72.
    1. O’Malley PG, Jackson JL, Santoro J et al. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract 1999; 48: 980-90.
    1. Kroenke K, Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosomat 2000; 69: 205-15.